Qiagen N.V. (QGEN)
$45.59
0.09 (0.20%)
QGEN Stock Quote Delayed 30 Minutes
QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024
QGEN stock results show that Qiagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
10.39B
PE Ratio
30.80
EPS
1.48
Volume (Avg. Vol.)
1.03M
Day's Range
$45.53 - $46.06
52-Week Range
$34.74 - $47.44
Dividend & Yield
N/A (N/A)
QGEN Stock Predictions, Articles, and Qiagen N.V. News
Qiagen NV (QGEN) a Hold on Anemic Industry Group Rank
Qiagen NV (NASDAQ:QGEN) is ranked as a Hold using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month.
Qiagen NV (QGEN) Sales Growth Restrict Rating
Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. QGEN has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.
Vapid Quant Score Hurt Qiagen NV (QGEN) Rating
Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. QGEN has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.
Weak Earnings Growth Drops Qiagen NV (QGEN) to Hold
With a $7.2 billion market value, Qiagen NV (NASDAQ:QGEN) ranks in the top half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, in market value. From the prospective of investment attractiveness, The current Portfolio Grader ranking for QGEN puts it 23 among the 33 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 453 among the 782 companies in the sector, and number 2,909 in the nearly 5,000 company Portfolio Grader universe.
Rating for Qiagen NV (QGEN) Drops….. Weak Industry Group Rank
Qiagen NV (NASDAQ:QGEN) is one of 33 companies within the Life Sciences Tools & Services GICS industry group, which is in turn part of the 785 company GICS Health Care sector. QGEN has a market value of $7.7 billion which is in the top half of its industry group. The ranking for QGEN by Portfolio Grader places it 21 among the 33 companies in this industry group, giving it a lower than average position; in the top half of the sector with a ranking of 338 among the 785 companies in the sector, and number 2,179 in the nearly 5,000 company Portfolio Grader universe.
Robust Quant Score Keeps Qiagen NV (QGEN) a Buy
Qiagen NV (NASDAQ:QGEN) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. QGEN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Healthy Earnings Momentum Keeps Qiagen NV (QGEN) a Buy
Portfolio Grader currently ranks Qiagen NV (NASDAQ:QGEN) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. QGEN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Analytics for Quant Score Drive Upgrade of Qiagen NV (QGEN) to Buy
Qiagen NV (NASDAQ:QGEN) is a component of the 33 company Life Sciences Tools & Services GICS industry group, which is a segment of the 783 company GICS Health Care sector. The market value of QGEN is $7.9 billion which falls in the top quarter of its industry group. Portfolio Grader's current ranking for QGEN puts it 13 among the 33 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 175 among the 783 companies in the sector, and number 1,279 in the nearly 5,000 company Portfolio Grader universe.
Qiagen NV (QGEN) Hold Recommendation Confirmed
Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. QGEN has maintained this ranking for the last month.
Qiagen NV (QGEN) Hold Recommendation Confirmed
Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. QGEN has maintained this ranking for the last month.
11 Life Sciences Tools & Services Stocks to Sell Now
The overall ratings of 11 Life Sciences Tools & Services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Life Sciences Tools & Services Stocks to Sell Now
The ratings of 5 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Life Sciences Tools & Services Stocks to Sell Now
This week, the ratings of 5 Life Sciences Tools & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – MPG LSCC TROX ROG
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Danaher Corporation (DHR) Buys Cepheid (CPHD): Who’s Next?
Genetic testing biotech stocks are in focus after Danaher (DHR) bought out Cepheid (CPHD). ILMN, MYGN or QGEN stock could be acquired next!
Why Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks
Earnings and takeover speculation made CRR, HPE and QGEN three of Friday's best stocks.
Hottest Manufacturing Stocks Now – EVOK BGS NR EMAN
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
4 Life Sciences Tools & Services Stocks to Sell Now
The ratings of 4 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – NDSN TTNP XONE CEMP
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Healthcare Stocks Now – MDCO SCMP CEMP ACOR
Healthcare stocks declined 0.4% on Wall Street on Friday morning.
